
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.38 | 10.5555555556 | 3.6 | 4.462 | 3.44 | 35725 | 3.95819008 | CS |
4 | 0.94 | 30.9210526316 | 3.04 | 5.2683 | 2.65 | 205642 | 3.75383975 | CS |
12 | 1.63 | 69.3617021277 | 2.35 | 5.2683 | 2.3186 | 70153 | 3.69782103 | CS |
26 | -0.09 | -2.2113022113 | 4.07 | 5.2683 | 2.2 | 36264 | 3.66581632 | CS |
52 | -0.18 | -4.32692307692 | 4.16 | 5.2683 | 2.2 | 27682 | 3.7772878 | CS |
156 | -5.203 | -56.6590438854 | 9.183 | 10 | 2.2 | 28366 | 4.59726711 | CS |
260 | -6.12 | -60.5940594059 | 10.1 | 58.5 | 2.2 | 800183 | 28.60501661 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions